WallStreetZenWallStreetZen

NASDAQ: TIL
Instil Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for TIL

Based on 3 analysts offering 12 month price targets for Instil Bio Inc.
Min Forecast
$11.00+5.67%
Avg Forecast
$27.67+165.77%
Max Forecast
$54.00+418.73%

Should I buy or sell TIL stock?

Based on 3 analysts offering ratings for Instil Bio Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 66.67%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TIL stock forecasts and price targets.

TIL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-12
lockedlocked$00.00+00.00%2024-03-25
lockedlocked$00.00+00.00%2024-01-19

1 of 1

Forecast return on equity

Is TIL forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is TIL forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TIL revenue forecast

What is TIL's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$5.0M
Avg 2 year Forecast
$5.0M
Avg 3 year Forecast
$5.0M

TIL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TIL$10.41$27.67+165.77%Buy
LABP$21.75$20.42-6.11%Hold
MNOV$1.40N/AN/A
PASG$1.20$9.50+691.67%Strong Buy
CSBR$5.07N/AN/A
View Top Biotech Stocks

Instil Bio Stock Forecast FAQ

Is Instil Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: TIL) stock is to Buy TIL stock.

Out of 3 analysts, 0 (0%) are recommending TIL as a Strong Buy, 2 (66.67%) are recommending TIL as a Buy, 1 (33.33%) are recommending TIL as a Hold, 0 (0%) are recommending TIL as a Sell, and 0 (0%) are recommending TIL as a Strong Sell.

If you're new to stock investing, here's how to buy Instil Bio stock.

What is TIL's revenue growth forecast for 2027-2029?

(NASDAQ: TIL) Instil Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Instil Bio's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast TIL's revenue for 2027 to be $32,519,565, with the lowest TIL revenue forecast at $32,519,565, and the highest TIL revenue forecast at $32,519,565. On average, 1 Wall Street analysts forecast TIL's revenue for 2028 to be $32,519,565, with the lowest TIL revenue forecast at $32,519,565, and the highest TIL revenue forecast at $32,519,565.

In 2029, TIL is forecast to generate $32,519,565 in revenue, with the lowest revenue forecast at $32,519,565 and the highest revenue forecast at $32,519,565.

What is TIL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TIL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is TIL's Price Target?

According to 3 Wall Street analysts that have issued a 1 year TIL price target, the average TIL price target is $27.67, with the highest TIL stock price forecast at $54.00 and the lowest TIL stock price forecast at $11.00.

On average, Wall Street analysts predict that Instil Bio's share price could reach $27.67 by Apr 12, 2025. The average Instil Bio stock price prediction forecasts a potential upside of 165.77% from the current TIL share price of $10.41.

What is TIL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TIL) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.